$NVCR $ZLAB .. Zai Lab and Novocure Announce First Patient Enrolled in a Phase 2 Pilot Trial of Tumor Treating Fields Together with Chemotherapy as First-Line Treatment of Gastric Cancer finance.yahoo.com/news/zai-... “Tumor Treating Fields is already approved for glioblastoma and malignant pleural mesothelioma in the U.S.,” added William Doyle, Executive Chairman of Novocure. “We are moving forward with multiple clinical trials to evaluate Tumor Treating Fields for other indications including brain metastases, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. It is very gratifying to see our partner engaged in active dialogue with the NMPA and studying Tumor Treating Fields for gastric cancer, a serious and unmet medical need in China.”
  • 1